Through this signalling pathway, mutations in Grb7 may cause endothelial dysfunction through reduced angiogenetic activity both through changes in intracellular calcium signalling and the VEGF/Akt (PKB)/NO pathway (Andrew and Mayer, 1999; Sahlberg et al., 2013). This evidence concerns the gene VEGFA and endothelial dysfunction.